Concerns about the impact of Medicare drug price negotiations, regular pipeline setbacks, Federal Trade Commission’s increasing scrutiny of mergers and acquisitions (M&As) in the sector and macroeconomic uncertainty and inflation remain. Trailing 12-Month Price-to-Sales (P/S) Ratio 5 Drug Stocks to Keep an Eye On Journey Medical: This Scottsdale, AZ-based company markets eight branded and two generic products to treat some common skin conditions. LYR-210 and LYR-220 are bioresorbable nasal implants designed to deliver six months of continuous anti-inflammatory medication to the sinonasal passages for the treatment of CRS, a highly prevalent inflammatory disease of the paranasal sinuses.